Von Hippel-Lindau Syndrome Therapeutics - Pipeline Analysis 2020, Clinical Trials & Results

Von Hippel-Lindau syndrome is a genetic disorder characterized by formation of cysts and tumors in different parts of the body. The symptoms associated with the disease depends upon the location of tumor. However, gait disturbance, dizziness, weakness of the limbs, deafness,...

Read More

Focal Segmental Glomerulosclerosis (FSGS) Therapeutics - Pipeline Analysis 2020, Clinical Trials & Results

Focal segmental glomerulosclerosis (FSGS) is a glomerular disease, which is characterized by scarring or sclerosis in the kidney. Scarring damages the limited number of glomeruli in the initial stages. It is more common in males than in females, and is very common in African...

Read More

Tic Disorder Therapeutics - Pipeline Analysis 2020, Clinical Trials & Results, Patents, Designations, Collaborations

Tic disorder is a type of mental disorder, characterized by sudden and nonrhythmic movements. According to the World Health Organisation (WHO), this disease can be categorized into five types; transient, combined vocal and multiple motor, unspecified, and chronic motor tic...

Read More

Spasticity Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations, Collaborations

Spasticity is a condition in which certain muscles are continuously contracted. The constant muscle contraction causes stiffness or tightness of the muscles and can interfere with normal movement, speech and gait in a patient. Access Detailed Report Summary: https://www.pharmaproff.com/report/spasticity-therapeutics-pipeline-analysis Spasticity is...

Read More

Polymyalgia Rheumatica Therapeutics - Pipeline Analysis, Clinical Trials & Results

Polymyalgia rheumatica is an inflammatory disorder which causes stiffness and aching, and usually affects adults over the age of 50 years. This disease affects women somewhat more than men. The cause of polymyalgia rheumatica is unknown. Access Detailed Report Summary: https://www.pharmaproff.com/report/polymyalgia-rheumatica-therapeutics-pipeline-analysis Polymyalgia...

Read More

Tagraxofusp - API Insight by Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Tagraxofusp was developed...

Read More

Androgenetic Alopecia Therapeutics Pipeline Analysis by Stages, Drug Class, Company Profile, Phase of Development, Clinical Trial & Discovery Stage Insights

Androgenetic Alopecia Therapeutics – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2019 published by Pharma Proff, androgenetic alopecia therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates. Androgenetic Alopecia...

Read More

Adrenoleukodystrophy (ALD) Therapeutics Pipeline Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy and Regulatory Landscape

Adrenoleukodystrophy (ALD) Therapeutics Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, ALD currently exhibits a proliferating pipeline with 10 therapeutic candidates. ALD Pipeline...

Read More

Musculoskeletal Pain Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Musculoskeletal pain is a known consequence of repetitive strain, overuse, and work-related musculoskeletal disorders. These injuries include a variety of disorders that cause pain in muscles, bones, joints, or surrounding structures. This pain can be acute or chronic, diffuse...

Read More

Intermittent Claudication Therapeutics - Pipeline Analysis, Clinical Trials & Results

Intermittent claudication refers to aching or squeezing pain in thighs, buttocks or feet during exercise, due to insufficient blood circulation resulting from peripheral arterial disease. The probability of developing peripheral arterial disease increases with the age. Request to...

Read More

Angioimmunoblastic T-Cell Lymphoma (AITL) Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations

Angioimmunoblastic T-cell lymphoma is a rare type of peripheral T-cell lymphoma which is characterized by lymphadenopathy, fever, and arthritis. The signs and symptoms associated with the disease include pleural effusion, arthritis, edema, ascites and pruritic skin rash....

Read More

Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics - Pipeline Analysis , Clinical Trials & Results

Fibrodysplasia ossificans progressiva (FOP), also known as myositis ossificans progressive, is a rare inherited connective tissue disorder characterized by abnormal bone development in ligaments, tendons, and skeletal muscles. Precisely, FOP causes the body's skeletal...

Read More

Hypopharyngeal Cancer Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations

Hypopharyngeal cancer, a type of head and neck cancer, develops in hypopharynx. Pharynx is a hollow tube about five inches long, and the bottom part of the pharynx called hypopharynx. Most of the hypopharyngeal malignancy occurs in squamous cells. Some of the major risk...

Read More

Visceral Pain Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations, Collaborations

Visceral pain is the most frequent form of clinically relevant pain for those patients seek medical attention. There are several causes of visceral pain. Nociceptive pain causes direct injury of an internal organs, that leads to cardiac ischemic, and peptic ulcer. Medications...

Read More

Tay-Sachs Disease Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Tay-Sachs is a lysosomal storage disorder caused by the deficiency of vital enzymes called beta-hexosaminidase A (Hex-A). The role of Hex-A is to degrade a fatty substance or lipid called GM-2 ganglioside. In the absence of the Hex-A enzymes, GM-2 accumulates abnormally in...

Read More